Table 3 GWAS data sets used in our MR analysis in the present study.
Traits | Pop | k1/k0 | N (case/control) | Data source |
|---|---|---|---|---|
ALS | EUR | 80,610 (20,806/59,804) | AVS20 | |
HDL | EUR | 85/87 | 93,561 | GLGC61 |
LDL | EUR | 78/78 | 89,138 | GLGC61 |
TC | EUR | 86/86 | 93,845 | GLGC61 |
TG | EUR | 53/54 | 90,263 | GLGC61 |
LTL | EUR | 7/7 | 37,684 | ENGAGE21 |
FTD | EUR | 12,928 (3,526/9,402) | IFGC36 | |
HDL | EUR | 79/87 | 93,561 | GLGC61 |
LDL | EUR | 66/78 | 89,138 | GLGC61 |
TC | EUR | 76/86 | 93,845 | GLGC61 |
TG | EUR | 47/54 | 90,263 | GLGC61 |
LTL | EUR | 6/7 | 37,684 | ENGAGE21 |
ALS | Asian | 4,084 (1,234/2,850) | Benyamin37 | |
HDL | Asian | 30/31 | 70,657 | Kanai89 |
LDL | Asian | 21/22 | 72,866 | Kanai89 |
TC | Asian | 31/32 | 128,305 | Kanai89 |
TG | Asian | 26/26 | 105,597 | Kanai89 |
LTL | Asian | 8/10 | 23,096 | SCHS22 |